altimmune glp-1 GSK shares rise as $2.5B cost-cutting plan unveiled • FDA says Replimune's melanoma data package is 'not interpretable,' setting up tough adcomm • rises as GLP-1/GIP drug curbs heavy drinking Altimmune hits NASH target in
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





















